It just goes to show that you can't keep a good stock down,indefinitely.
If this were a stock that was in Phase 1 trials and there was uncertainty as to their direction going forward,that's one thing.
Trius has completed Phase 3 trials,is beginning the trial phase for pneumonia and is working with the government via grants.
For reasons I have in the past and releases show,this company is a triple threat in the field of infectious diseases.
The drugs they are producing not only help current situations but will be that "insurance policy" in the event of necessity.
This is more than a mere stock play for my concerns;it's a potential life-saver.
It is said that it's better to have something and not need it,than to need something and not have it.
I believe all bases are covered here.
While some are merely in the batter's box or on second (metaphorically speaking),this company is rounding third base.
TSRX,with approval from the continents at large,will help in ways that haven't even been proposed yet.
Take Care and God Bless....God Bless Us All.
Truth4Once
Market Data 
Markets 
AI
